We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PPH:JSEPepkor Holdings Ltd. Analysis

Data as of 2026-03-11 - not real-time

ZAC 2,391.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Pepkor Holdings is trading at ZAc 2,391, well below its 20‑day (ZAc 2,560) and 50‑day (ZAc 2,600) simple moving averages, signalling a bearish technical backdrop. The 14‑day RSI sits near 36, hinting at mild oversold conditions, yet the MACD remains in a bearish configuration with the line under the signal, reinforcing downside momentum. Volume is on the rise, but price is testing a near‑term support around ZAc 2,311 while facing resistance near ZAc 2,710, suggesting limited upside in the short run.
On the fundamentals side, Pepkor posted 11% revenue growth and healthy gross margins close to 40%, but its balance sheet is leveraged with a debt‑to‑equity ratio above 42, and a price‑to‑book of 140× signals significant overvaluation relative to its book value. The company generates solid operating cash flow and pays a 2.16% dividend with a modest 32% payout ratio, indicating dividend sustainability. However, the discounted cash‑flow fair value of roughly ZAc 1,160 is far below the current market price, highlighting a sizeable valuation gap that, combined with elevated 30‑day volatility (~29%) and a low beta, points to heightened downside risk despite the sector’s growth potential.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages and support level
  • Bearish MACD and negative momentum
  • Valuation significantly above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Steady revenue growth and solid margins
  • Sustainable dividend yield with low payout ratio
  • High leverage and overvaluation temper optimism

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Expansive footprint across emerging African markets
  • Potential for cash‑flow driven debt reduction
  • Long‑term growth prospects offset by valuation premium

Key Metrics & Analysis

Financial Health

Revenue Growth11.10%
Profit Margin5.91%
P/E Ratio15.8
ROE9.24%
ROA6.18%
Debt/Equity42.54
P/B Ratio139.5
Op. Cash FlowZAC6.3B
Free Cash FlowZAC2.9B

Technical Analysis

TrendBearish
RSI36.0
SupportZAC 2,311.00
ResistanceZAC 2,710.00
MA 20ZAC 2,560.00
MA 50ZAC 2,599.74
MA 200ZAC 2,634.35
MACDBearish
VolumeIncreasing
Fear & Greed Index76.79

Valuation

Fair ValueZAC 1,161.63
Target PriceZAC 3,209.38
Upside/Downside34.23%
GradeOvervalued
TypeBlend
Dividend Yield2.16%

Risk Assessment

Beta0.42
Volatility29.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.